ENZYMOLOGY
Prof (Dr) Viyatprajna Acharya
MD, PhD
KIMS, KIIT (DU)
What shall we learn?
Why should we learn about enzymes?
Why nursing staff should know about them?
Who thought about them first?- History
How do we define them?
How do we name them?- The classification
Definition
Enzymes are “Biocatalysts”, synthesized by living
cells and highly specific in their action.
They are:
Mostly proteins (Exception- Ribozymes)
Heat labile
Soluble in water
Colloidal
Precipitated by precipitation reaction
Contain 16% weight as nitrogen
Classification & Nomenclature
A. Recommended name
B. Systematic name
IUBMB
Unambiguous & Informative
But Cumbersome
6 major classes
Class.Subclass.sub-subclass.substrate
OTHLIL
Oxidoreductases→ Transfer of H, O or e-
Transferases → Transfer of gr other than H
Hydrolases → Cleave bond & add H2O
Lyases → Cleave bond without adding H2O
Isomerases → Intramolecular transfers
Ligases → ATP dependent condensation of 2 molecules
1. Oxidoreductases
AH2 + B →A + BH2
Alcohol+ NAD+ ADH Aldehyde + NADH +H+
• Dehydrogenases (hydride transfer)- ADH
• Oxidases (electron transfer to molecular oxygen)- L-
and D- AA oxidase
• Oxygenases (oxygen transfer from molecular
oxygen)- oxygenase, mono- & di-oxygenases,
Cytochrome oxidase
• Peroxidases (electron transfer to peroxide)-
Glutathione peroxidase
2. Transferases
A-R + B → A + B-R
• transfer of an atom or group of atoms
(e.g. acyl-, alkyl- and glycosyl- ), between
two molecules, but excluding such
transfers as are classified in the other
groups (e.g. Oxidoreductases and
Hydrolases).
• Ex- Aminotransferases, all kinases,
transmethylases
• Hexose + ATP Hexokinase Hexose-6-P +
ADP
3. Hydrolases
Cleavage of ester, ether, peptide or
glycosidic bond by addition of H2O
Ach + H2O acetylcholine esterase Choline +
Acetate
Ex: All digestive enzymes, lipase, pepsin,
Trypsin, ALP, Urease
4. Lyases
Cleave bond without addition of H2O
Fructose-1,6-BP Aldolase Glyceraldehyde-3-
P
+ Dihydroxyacetone P
Ex: Fumarase, Histidase, HMG CoA lyase
5. Isomerases
Can produce optical, geometrical or
positional isomers of substrates
Gly-3-P Triose P isomerase DHAP
Ex: Racemase, Epimerase
6. Ligases (synthetases)
ATP dependent condensation of two
molecules
Acetyl CoA + CO2 + ATP Acetyl CoA Carboxylase
Malonyl CoA + ADP + Pi
Synthases and synthetases are different
!!!
Synthatase- need ATP; Synthase- no ATP
Ex: Glycogen synthase, ALA synthase
Some Terminologies
Active Site
 Region where substrate binds
 Occupies a very small portion of the enzyme
 Situated in a crevice or a cleft
 During binding specific groups realign themselves to fit
exactly
 Substrate binds by non-covalent bonds
 AA or grs. That directly participate in binding are
known as catalytic residues
 Sometimes catalytic site and substrate binding site may
be different
 Coenzymes and cofactors are a part of the catalytic site
 Serine- frequently present
Active site
Specificity
• Highly specific
• Interacting with one or few substrates
• Catalyze only one reaction
Types of specificity
• Absolute specificity
• Group specificity
• Bond specificity
• Stereo specificity
Cofactor/ Coenzyme
• Holoenzyme → Apoenzyme + Coenzyme
(Active enzyme) (Protein part) (Non-Prot.
part)
• Some enzymes require Metal (Zn, Fe),
organic molecules (coenzymes)
• Inorganic ions- Activators
Characteristics of coenzymes
I. When cofactor is some organic substance
II. Group is transferred from or accepted by the
coenzyme
III. Heat stable
IV. Low MW
V. Combine loosely with enzyme
VI. Separated by dialysis
VII. Reaction complete→ Coenzyme released →
Goes to other reaction site
Prosthetic group
• When cofactor (collectively includes coenzymes
and metal ions) is strongly bound to the
apoenzyme by covalent or non-covalent forces
• Ex: PLP, FMN, FAD, TPP, Biotin;
metal ions of Co, Cu, Mg, Mn, Se, and Zn
• Metals are most common
• 1/3rd enzymes contain metals- Metallozymes
/Metallo-enzymes
• Metals as cofactors- Metal activated enzymes
Metallo -enzymes
Metal Metal containing enzyme
Zn Carbonic anhydrase, Carboxypeptidase, ADH
Mg Hexokinase, PFK, Enolase, Glu-6-Phosphatase
Mn Phospho gluco mutase, Hexokinase, Enolase,
Glycosyl transferase
Cu Tyrosinase, cytochrome oxidase, SOD, Lysyl
oxidase
Fe cytochrome oxidase, catalase, peroxidase,
Xanthine oxidase
Ca Lecithinase, lipase
Se Glutathione peroxidase, Deiodinase
Mo Xanthine oxidase
Enzymology contd………….
He who angers you , conquers you.
Elizabeth Kenny
How enzymes work???
 Enzymes provide an alternate,
energetically favorable pathway different
from uncatalyzed reaction
 The active site chemically facilitates
catalysis
A. Energy changes occurring during reaction
A ↔ T* ↔ B
Energy barrier separates reactants and products.
Energy barrier- Free energy of activation
↓
Energy difference between reactants and high energy
intermediate T*
a) Free energy of activation
 Uncatalyzed reactions- high EA
 Rate of reactions thus slow
Visualization of the transition state
Koshland’s Induced fit model
Substrate induces conformational changes in enzyme
Factors affecting enzyme
action
Prof. Dr. Viyatprajna Acharya
Enzymes can be isolated and
properties can be studied in vitro
Factors affecting enzymes are:
1. Concentration of enzyme
2. Concentration of substrate
3. Concentration of product
4. Temperature
5. pH
6. Activators
7. Time
8. Light & radiation
9. Inhibitors
1. Enzyme concentration
affecting enzyme activity
 When substrate is sufficient,
Rate of reaction is proportional to
Enzyme concentration
 Unit of enzyme activity- IU, Katal
(Kat), U, KAU
2. Substrate concentration
affecting enzyme activity
E + S ↔ ES ↔ E + P
A
B
C
3 Phases
A. At low substrate
conc.– V α [S]
B. [S] not directly
proportional to V
C. Reaction
independent of [S]
Most of the enzymes follow
Michelis-Menten kinetics
MICHELIS-MENTEN EQUATION
Enzyme combines reversibly with
substrate to form ES.
Breakdown of ES to product is
irreversible.
E= Enzyme
S= Substrate
P= Product
Es= Enz- substrate complex
K1, K-1, K2= Rate constants
Michelis constant
Km = K1+ K2
K
1
After algebraic manipulation
Km/ Michelis constant
 It’s the substrate concentration (expressed in
moles/lit) at half-maximal velocity.
 50% of enzyme molecules are bound with
substrate molecules at that particular substrate
concentration
 Km is independent of enzyme concentration
 Expressed in moles/lit
 Km is a constant for an enzyme. It’s the
characteristic feature of a particular enzyme for a
specific substrate- Signature of the enzyme
 Km is the representative of measuring
the strength of the ES complex
Low Km – strong affinity between enzyme
and substrate
Ex: Glucokinase– Km= 10 mmol /lit
Hexokinase– Km= 0.05 mmol/lit
So what’s the inference??
50% molecules of Hexokinase are
saturated even at a lower conc. Of
glucose.
 When [S] << Km → reaction is first-
order
 When [S] >> Km → reaction is zero-
order
Double reciprocal curve
Cooperative binding
5. Effect of pH
pH change alters:
 Ionization states of the amino acid residues
present in the active site
 Ionization state of substrate
 May dissociate apoenzyme from cofactor
 Drastic change denatures the enzyme protein
Optimum pH is different for different enzymes
Mostly 6-8
Exception: Pepsin– 1-2
ALP– 9-10
Acid phosphatase – 4-5
pH affecting enzyme activity
A bell-shaped curve
6. Effect of activators
 Inorganic metal ions increase enzyme
activity
Ex: Mg, Mn, Zn, Co, Cu etc
Cl - - Salivary amylase
Ca++ - Lipase
7. Effect of Time
 Under ideal and optimal conditions,
the time required for an enzyme
reaction is less
8. Effect of light and
radiation
 UV rays,β, γ, X- rays inactivate
Enzyme Inhibition
Prof. (Dr.) V.P. Acharya
Many different kinds of molecules inhibit
enzymes and act in a variety of ways
Enzyme inhibition
Competitive
Non-competitive
Reversible Irreversible
Uncompetitive
Suicide
Allosteric
Feedback
Competitive inhibition
• Inhibitor competes with the substrate for the active
site
• Inhibitor is substrate analogue
• Usually reversible
• ↑ [S] abolishes inhibition
• ↓ velocity of reaction
• ↑ Km
• Vmax unchanged
COMPETITIVE
INHIBITION
Non-competitive inhibition
• No competition between substrate and
inhibitor
• Different binding sites
• No structural similarities
• ↑ [S] doesn’t resolve the inhibition
• Usually irreversible
• May be reversible when inhibitor is
removed
• Km value unchanged
• Vmax reduces
Clinical significance
• Cyanide inhibits cytochrome oxidase
• F inhibits enolase- removes Mn & Mg
• Heavy metals react with –SH gr. Of BAL-
hence BAL is used in heavy metal
poisoning
Toxicological importance
• Most of the poisons- Irreversible NC
inhibitors- iodoacetate, heavy metal
poisons
Competitive Vs Non-competitive inhibition
Competitive
inhibition
Non-competitive
inhibition
Act on Active site May/may not be
Str of inhibitor Substrate
analogue
Not an analogue
Reversibility Reversible Mostly irreversible
↑ Substrate Inhibition relieved No effect
Km ↑ No change
Vmax Unchanged ↓
Significance Drug action Toxicological
How Isozymes help in Medicine??
 Diagnosis
 Prognosis
 Treatment
 Biochemical assays
LDH iso -enzymes
No. of
isozyme
Subunit
Make
up
Tissue of origin % in
human
serum
LDH-1 H4 Heart muscle 30
LDH-2 H3M1 RBC 35
LDH-3 H2M2 Brain 20
LDH-4 H1M3 Liver, Skeletal muscle 10
LDH-5 M4 Liver, Skeletal muscle 5
Clinical application of LDH
 Myocardial infarction-LDH-1> LDH-2;
flipped pattern see in MI (usually LDH-2 >
LDH-1)
↑LDH-1, LDH-2- peaks at 72hrs and
stays till 1 week
 Muscular dystrophies- ↑LDH-5
 Hepatocellular damage- ↑LDH-5
 Megaloblastic anemia, renal infarction-
↑LDH-1, LDH-2
 Cancers- ↑↑↑
Creatine kinase
 Normal serum level- 15-100 U/L for males;
10-80 U/L for females
 Dimer, 2 units M &B
 3 isoenzymes
 MM (CK3)- Skeletal Mm.
 MB (CK2)- Heart Mm.
 BB (CK1)- Brain
Clinical application of
CK
 Myocardial infarction
 Muscular dystrophies
 CK-MB peaks after AMI at 10-24 hrs, returns
to normal within 2-3 days
Aspartate transaminase
 SGOT
 PLP as coenzyme
 Normal serum level- 5-40 U/L
 ↑ in MI
 Moderate ↑ in liver diseases
Alanine Transaminase
 SGPT
 PLP is the coenzyme
 Normal level- 5-40 U/L
 ↑ level- acute hepatitis
 Moderate ↑- Chronic liver disease,
cirrhosis, hepatitis-C
Alkaline Phosphatase
 Found in almost all tissues
 Present in cell membrane (Ecto -enzyme)
 Hydrolyses aliphatic, aromatic &
heterocyclic compounds
 Optimum pH- 9- 10
 Normal level- 80-125 U/L
 Moderate ↑- infective, alcoholic
hepatitis, CA liver
 Very high ↑- Obstructive jaundice,
toxic hepatitis
 ↑ ↑ ↑- Bone diseases
Enzyme patterns in
diseases
1. Hepatic diseases: ALT
AST
ALP
NTP
GGT
2. Cardiac markers:
a) Enzymatic markers
 LDH
 AST
 CK-MB
b) Non- enzymatic markers
 Troponin T & I
 Myglobin
 BNP
 Copeptin
3. Muscle disease
 CK-MM
 AST
 Aldolase
4. Bone disease
ALP
5. Prostate cancer
 Prostate specific antigen
 Acid phosphatase
Therapeutic use of enzymes
ENZYME THERAPEUTIC
APPLICATION
Asparginase ALL
Streptokinase, Urokinase Lyse intravascular clot
Streptodornase DNAse; applied locally
Pancreatin Pancreatic insufficiency
Papain Anti-inflammatory
Alpha-1-antitrypsin Emphysema
Enzymes in diagnostic assays
 Glucose oxidase- glucose
 Urease- urea
 Taq Polymerase- PCR
 Reverse transcriptase- Recombinant DNA
technology
 Horse radish peroxidase- ELISA
For more Medical Biochemistry ppt please
visit www.vpacharya.com

Enzymology for B.Sc. nursing students

  • 1.
    ENZYMOLOGY Prof (Dr) ViyatprajnaAcharya MD, PhD KIMS, KIIT (DU)
  • 2.
    What shall welearn? Why should we learn about enzymes? Why nursing staff should know about them? Who thought about them first?- History How do we define them? How do we name them?- The classification
  • 4.
    Definition Enzymes are “Biocatalysts”,synthesized by living cells and highly specific in their action. They are: Mostly proteins (Exception- Ribozymes) Heat labile Soluble in water Colloidal Precipitated by precipitation reaction Contain 16% weight as nitrogen
  • 5.
    Classification & Nomenclature A.Recommended name B. Systematic name IUBMB Unambiguous & Informative But Cumbersome 6 major classes Class.Subclass.sub-subclass.substrate
  • 7.
    OTHLIL Oxidoreductases→ Transfer ofH, O or e- Transferases → Transfer of gr other than H Hydrolases → Cleave bond & add H2O Lyases → Cleave bond without adding H2O Isomerases → Intramolecular transfers Ligases → ATP dependent condensation of 2 molecules
  • 8.
    1. Oxidoreductases AH2 +B →A + BH2 Alcohol+ NAD+ ADH Aldehyde + NADH +H+ • Dehydrogenases (hydride transfer)- ADH • Oxidases (electron transfer to molecular oxygen)- L- and D- AA oxidase • Oxygenases (oxygen transfer from molecular oxygen)- oxygenase, mono- & di-oxygenases, Cytochrome oxidase • Peroxidases (electron transfer to peroxide)- Glutathione peroxidase
  • 9.
    2. Transferases A-R +B → A + B-R • transfer of an atom or group of atoms (e.g. acyl-, alkyl- and glycosyl- ), between two molecules, but excluding such transfers as are classified in the other groups (e.g. Oxidoreductases and Hydrolases). • Ex- Aminotransferases, all kinases, transmethylases • Hexose + ATP Hexokinase Hexose-6-P + ADP
  • 10.
    3. Hydrolases Cleavage ofester, ether, peptide or glycosidic bond by addition of H2O Ach + H2O acetylcholine esterase Choline + Acetate Ex: All digestive enzymes, lipase, pepsin, Trypsin, ALP, Urease
  • 11.
    4. Lyases Cleave bondwithout addition of H2O Fructose-1,6-BP Aldolase Glyceraldehyde-3- P + Dihydroxyacetone P Ex: Fumarase, Histidase, HMG CoA lyase
  • 12.
    5. Isomerases Can produceoptical, geometrical or positional isomers of substrates Gly-3-P Triose P isomerase DHAP Ex: Racemase, Epimerase
  • 13.
    6. Ligases (synthetases) ATPdependent condensation of two molecules Acetyl CoA + CO2 + ATP Acetyl CoA Carboxylase Malonyl CoA + ADP + Pi Synthases and synthetases are different !!! Synthatase- need ATP; Synthase- no ATP Ex: Glycogen synthase, ALA synthase
  • 16.
    Some Terminologies Active Site Region where substrate binds  Occupies a very small portion of the enzyme  Situated in a crevice or a cleft  During binding specific groups realign themselves to fit exactly  Substrate binds by non-covalent bonds  AA or grs. That directly participate in binding are known as catalytic residues  Sometimes catalytic site and substrate binding site may be different  Coenzymes and cofactors are a part of the catalytic site  Serine- frequently present
  • 17.
  • 18.
    Specificity • Highly specific •Interacting with one or few substrates • Catalyze only one reaction
  • 19.
    Types of specificity •Absolute specificity • Group specificity • Bond specificity • Stereo specificity
  • 20.
    Cofactor/ Coenzyme • Holoenzyme→ Apoenzyme + Coenzyme (Active enzyme) (Protein part) (Non-Prot. part) • Some enzymes require Metal (Zn, Fe), organic molecules (coenzymes) • Inorganic ions- Activators
  • 21.
    Characteristics of coenzymes I.When cofactor is some organic substance II. Group is transferred from or accepted by the coenzyme III. Heat stable IV. Low MW V. Combine loosely with enzyme VI. Separated by dialysis VII. Reaction complete→ Coenzyme released → Goes to other reaction site
  • 22.
    Prosthetic group • Whencofactor (collectively includes coenzymes and metal ions) is strongly bound to the apoenzyme by covalent or non-covalent forces • Ex: PLP, FMN, FAD, TPP, Biotin; metal ions of Co, Cu, Mg, Mn, Se, and Zn • Metals are most common • 1/3rd enzymes contain metals- Metallozymes /Metallo-enzymes • Metals as cofactors- Metal activated enzymes
  • 23.
    Metallo -enzymes Metal Metalcontaining enzyme Zn Carbonic anhydrase, Carboxypeptidase, ADH Mg Hexokinase, PFK, Enolase, Glu-6-Phosphatase Mn Phospho gluco mutase, Hexokinase, Enolase, Glycosyl transferase Cu Tyrosinase, cytochrome oxidase, SOD, Lysyl oxidase Fe cytochrome oxidase, catalase, peroxidase, Xanthine oxidase Ca Lecithinase, lipase Se Glutathione peroxidase, Deiodinase Mo Xanthine oxidase
  • 24.
    Enzymology contd…………. He whoangers you , conquers you. Elizabeth Kenny
  • 25.
    How enzymes work??? Enzymes provide an alternate, energetically favorable pathway different from uncatalyzed reaction  The active site chemically facilitates catalysis
  • 26.
    A. Energy changesoccurring during reaction A ↔ T* ↔ B Energy barrier separates reactants and products. Energy barrier- Free energy of activation ↓ Energy difference between reactants and high energy intermediate T*
  • 27.
    a) Free energyof activation  Uncatalyzed reactions- high EA  Rate of reactions thus slow
  • 28.
    Visualization of thetransition state
  • 29.
    Koshland’s Induced fitmodel Substrate induces conformational changes in enzyme
  • 31.
  • 32.
    Enzymes can beisolated and properties can be studied in vitro Factors affecting enzymes are: 1. Concentration of enzyme 2. Concentration of substrate 3. Concentration of product 4. Temperature 5. pH 6. Activators 7. Time 8. Light & radiation 9. Inhibitors
  • 33.
    1. Enzyme concentration affectingenzyme activity  When substrate is sufficient, Rate of reaction is proportional to Enzyme concentration  Unit of enzyme activity- IU, Katal (Kat), U, KAU
  • 35.
    2. Substrate concentration affectingenzyme activity E + S ↔ ES ↔ E + P A B C 3 Phases A. At low substrate conc.– V α [S] B. [S] not directly proportional to V C. Reaction independent of [S]
  • 36.
    Most of theenzymes follow Michelis-Menten kinetics
  • 37.
    MICHELIS-MENTEN EQUATION Enzyme combinesreversibly with substrate to form ES. Breakdown of ES to product is irreversible. E= Enzyme S= Substrate P= Product Es= Enz- substrate complex K1, K-1, K2= Rate constants
  • 38.
    Michelis constant Km =K1+ K2 K 1 After algebraic manipulation
  • 39.
    Km/ Michelis constant It’s the substrate concentration (expressed in moles/lit) at half-maximal velocity.  50% of enzyme molecules are bound with substrate molecules at that particular substrate concentration  Km is independent of enzyme concentration  Expressed in moles/lit  Km is a constant for an enzyme. It’s the characteristic feature of a particular enzyme for a specific substrate- Signature of the enzyme
  • 40.
     Km isthe representative of measuring the strength of the ES complex Low Km – strong affinity between enzyme and substrate Ex: Glucokinase– Km= 10 mmol /lit Hexokinase– Km= 0.05 mmol/lit So what’s the inference??
  • 41.
    50% molecules ofHexokinase are saturated even at a lower conc. Of glucose.  When [S] << Km → reaction is first- order  When [S] >> Km → reaction is zero- order
  • 42.
  • 43.
  • 44.
    5. Effect ofpH pH change alters:  Ionization states of the amino acid residues present in the active site  Ionization state of substrate  May dissociate apoenzyme from cofactor  Drastic change denatures the enzyme protein Optimum pH is different for different enzymes Mostly 6-8 Exception: Pepsin– 1-2 ALP– 9-10 Acid phosphatase – 4-5
  • 45.
    pH affecting enzymeactivity A bell-shaped curve
  • 46.
    6. Effect ofactivators  Inorganic metal ions increase enzyme activity Ex: Mg, Mn, Zn, Co, Cu etc Cl - - Salivary amylase Ca++ - Lipase
  • 47.
    7. Effect ofTime  Under ideal and optimal conditions, the time required for an enzyme reaction is less
  • 48.
    8. Effect oflight and radiation  UV rays,β, γ, X- rays inactivate
  • 50.
  • 52.
    Many different kindsof molecules inhibit enzymes and act in a variety of ways Enzyme inhibition Competitive Non-competitive Reversible Irreversible Uncompetitive Suicide Allosteric Feedback
  • 53.
    Competitive inhibition • Inhibitorcompetes with the substrate for the active site • Inhibitor is substrate analogue • Usually reversible • ↑ [S] abolishes inhibition • ↓ velocity of reaction • ↑ Km • Vmax unchanged
  • 54.
  • 56.
    Non-competitive inhibition • Nocompetition between substrate and inhibitor • Different binding sites • No structural similarities • ↑ [S] doesn’t resolve the inhibition • Usually irreversible • May be reversible when inhibitor is removed • Km value unchanged • Vmax reduces
  • 58.
    Clinical significance • Cyanideinhibits cytochrome oxidase • F inhibits enolase- removes Mn & Mg • Heavy metals react with –SH gr. Of BAL- hence BAL is used in heavy metal poisoning Toxicological importance • Most of the poisons- Irreversible NC inhibitors- iodoacetate, heavy metal poisons
  • 59.
    Competitive Vs Non-competitiveinhibition Competitive inhibition Non-competitive inhibition Act on Active site May/may not be Str of inhibitor Substrate analogue Not an analogue Reversibility Reversible Mostly irreversible ↑ Substrate Inhibition relieved No effect Km ↑ No change Vmax Unchanged ↓ Significance Drug action Toxicological
  • 61.
    How Isozymes helpin Medicine??  Diagnosis  Prognosis  Treatment  Biochemical assays
  • 62.
    LDH iso -enzymes No.of isozyme Subunit Make up Tissue of origin % in human serum LDH-1 H4 Heart muscle 30 LDH-2 H3M1 RBC 35 LDH-3 H2M2 Brain 20 LDH-4 H1M3 Liver, Skeletal muscle 10 LDH-5 M4 Liver, Skeletal muscle 5
  • 63.
    Clinical application ofLDH  Myocardial infarction-LDH-1> LDH-2; flipped pattern see in MI (usually LDH-2 > LDH-1) ↑LDH-1, LDH-2- peaks at 72hrs and stays till 1 week  Muscular dystrophies- ↑LDH-5  Hepatocellular damage- ↑LDH-5  Megaloblastic anemia, renal infarction- ↑LDH-1, LDH-2  Cancers- ↑↑↑
  • 64.
    Creatine kinase  Normalserum level- 15-100 U/L for males; 10-80 U/L for females  Dimer, 2 units M &B  3 isoenzymes  MM (CK3)- Skeletal Mm.  MB (CK2)- Heart Mm.  BB (CK1)- Brain
  • 65.
    Clinical application of CK Myocardial infarction  Muscular dystrophies  CK-MB peaks after AMI at 10-24 hrs, returns to normal within 2-3 days
  • 66.
    Aspartate transaminase  SGOT PLP as coenzyme  Normal serum level- 5-40 U/L  ↑ in MI  Moderate ↑ in liver diseases
  • 67.
    Alanine Transaminase  SGPT PLP is the coenzyme  Normal level- 5-40 U/L  ↑ level- acute hepatitis  Moderate ↑- Chronic liver disease, cirrhosis, hepatitis-C
  • 68.
    Alkaline Phosphatase  Foundin almost all tissues  Present in cell membrane (Ecto -enzyme)  Hydrolyses aliphatic, aromatic & heterocyclic compounds  Optimum pH- 9- 10  Normal level- 80-125 U/L  Moderate ↑- infective, alcoholic hepatitis, CA liver  Very high ↑- Obstructive jaundice, toxic hepatitis  ↑ ↑ ↑- Bone diseases
  • 69.
    Enzyme patterns in diseases 1.Hepatic diseases: ALT AST ALP NTP GGT
  • 70.
    2. Cardiac markers: a)Enzymatic markers  LDH  AST  CK-MB b) Non- enzymatic markers  Troponin T & I  Myglobin  BNP  Copeptin
  • 71.
    3. Muscle disease CK-MM  AST  Aldolase 4. Bone disease ALP 5. Prostate cancer  Prostate specific antigen  Acid phosphatase
  • 72.
    Therapeutic use ofenzymes ENZYME THERAPEUTIC APPLICATION Asparginase ALL Streptokinase, Urokinase Lyse intravascular clot Streptodornase DNAse; applied locally Pancreatin Pancreatic insufficiency Papain Anti-inflammatory Alpha-1-antitrypsin Emphysema
  • 73.
    Enzymes in diagnosticassays  Glucose oxidase- glucose  Urease- urea  Taq Polymerase- PCR  Reverse transcriptase- Recombinant DNA technology  Horse radish peroxidase- ELISA
  • 74.
    For more MedicalBiochemistry ppt please visit www.vpacharya.com